What is CRMD's current stock price?

As of now, CRMD is trading at $10.95, with a daily change of -2.32%.

What are the risks associated with CRMD stock?

CRMD Key risk is its Moderate, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CRMD Stock Analysis & IQ Rating | CorMedix

CRMD

CorMedix

$10.95

-$0.26 | -2.32%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

TopRated Yesterday at 01:38

opens the day with a confident nod from RBC Capital, which maintained its Outperform rating and sees more than 70% upside ahead. For a healthcare operator navigating demand tailwinds, that’s a vote of confidence worth no...

CRMD Stock IQ

Login to see CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRMD Target Price

Login to display

Strengths

CRMD Rewards

Earnings are forecast to grow

CRMD Rewards

Expands stock buyback program

CRMD Rewards

Trading below its fair value

CRMD Rewards

Outperform the market

Chart

$10.17 (+7.67%)

$13.55 (-19.19%)

$14.97 (-26.85%)

$9.98 (+9.72%)

1year

6month

3month

1month

CRMD Risk Level

CRMD has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

CRMD Analysts Opinion

CRMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CRMD Analysts Opinion

CRMD Analysts opinion is positive and also has improved from the past 3 months

CRMD Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

96%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

75%

100%

CRMD Street Sentiment

CRMD Street Sentiment is extremely bullish and have positive views on the near-term outlook

CRMD Performance Sentiment

Sentiments overview associated with CRMD events and the stock performance.

96%

4%

Positive

Negative

22 out of 23
events present

1 out of 23
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.38

Resistance
Price

$10.08

Current Price Range

$12.16

Show methods +

Linked to CRMD

IQ

Close Price

Change

TLPH

3.50

1.08

+3.81%

CRMD Latest Analysis +

HC Wainwright & Co. Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 13 2025 HC Wainwright &. Co. maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 76.78% Upside

Today

$10.95 | -2.32%

Rating

CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript. CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript November 12 2025 CorMedix Inc. beats earnings expectations. Reported EPS is $1259.23 expectations were $0.48. Operator: Good day and welcome to the CorMedix Third Quarter 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn [….]

Thu Nov 13, 2025

$11.21 | -1.84%

Earnings

Needham Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 12 2025 Needham maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 73.23% Upside

Thu Nov 13, 2025

$11.21 | -1.84%

Rating

D. Boral Capital Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 12 2025 D. Boral Capital maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 73.23% Upside

Thu Nov 13, 2025

$11.21 | -1.84%

Rating

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations. CRMD) reported third-quarter earningsSales reached $104.27 million a jump from $11.5 million a year ago beating the .Net revenue of $104.3 million and pro forma net revenue of $130.8 million were primarily driven by higher-than-expected utilization of DefenCath by its .DefenCath sales contributed $88.8 million of net revenue in ...

Wed Nov 12, 2025

$11.38 | +2.06%

Earnings

Momentum

CorMedix GAAP EPS of $1.26 beats by $0.63 revenue of $104.28M beats by $18.26M.

Wed Nov 12, 2025

$11.38 | +2.06%

Earnings

CorMedix raises 2025 revenue guidance to $390M-$410M amid accelerated Melinta integration and DefenCath momentum.

Wed Nov 12, 2025

$11.38 | +2.06%

Potential

Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Heres What You Should Know. The mean of analysts price targets for CorMedix (CRMD) points to an 80.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Mon Nov 10, 2025

$11.05 | +2.97%

Potential

All You Need to Know About CorMedix (CRMD) Rating Upgrade to Strong Buy. CorMedix (CRMD) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

Tue Nov 4, 2025

$11.42 | -1.30%

Momentum

Rating

Tuesday 10/28 Insider Buying Report: CRMD XFOR. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Thursday CorMedixs Director Myron Kaplan made a $275500 buy of CRMD purcha

Tue Oct 28, 2025

$11.14 | +0.81%

Activity

Momentum

FAQ About CRMD Stock Insights

What is CRMD current stock price?

What are CRMD stock strengths?

What risks are associated with CRMD stock?

When is CRMD next earnings report?

What is CRMD market cap and volume?

What is CRMD's current Stock IQ?

Should I buy CRMD stock right now?

Is CRMD a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRMD?

What does a 'Strong Sell' rating mean for CRMD?

What factors influence CRMD's Stock IQ?

Explore our CRMD Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CRMD Stock Strategies
Effective Risk Management

FIND US ON

Receive our CRMD Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CRMD

CorMedix

Current Price

$10.95

-$0.26 | -2.32%

52W High

$ 17.43

MKT CAP

$ 860.37M

52W Low

$ 5.6

VOL

$ 358.17K

P/E Ratio

14.67

AVG VOL

$ 2.74M

RSI

45.97

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CRMD Rewards

Earnings are forecast to grow

CRMD Rewards

Expands stock buyback program

CRMD Rewards

Trading below its fair value

CRMD Rewards

Outperform the market

Linked to CRMD

Symbol

IQ

Close

Change

TLPH

3.50

1.08

+3.81%

CRMD Stock IQ

Login to unlock CorMedix (CRMD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$10.17 (+7.67%)

$13.55 (-19.19%)

$14.97 (-26.85%)

$9.98 (+9.72%)

1year

6month

3month

1month

CRMD Analysts Opinion

CRMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CRMD Analysts Opinion

CRMD Analysts opinion is positive and also has improved from the past 3 months

CRMD Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

96%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

75%

100%

CRMD Street Sentiment

CRMD Street Sentiment is extremely bullish and have positive views on the near-term outlook

CRMD Risk Level

CRMD has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

CRMD Performance Sentiment

Sentiments overview associated with CRMD events and the stock performance.

96%

4%

Positive

Negative

22 out of 23
events present

1 out of 23
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.38

Resistance
Price

$10.08

Current Price Range

$12.16

Show methods +

CRMD Latest Analysis

TopRated Yesterday at 01:38

opens the day with a confident nod from RBC Capital, which maintained its Outperform rating and sees more than 70% upside ahead. For a healthcare operator navigating demand tailwinds, that’s a vote of confidence worth no...

HC Wainwright & Co. Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 13 2025 HC Wainwright &. Co. maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 76.78% Upside

Today

$10.95 | -2.32%

Rating

CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript. CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript November 12 2025 CorMedix Inc. beats earnings expectations. Reported EPS is $1259.23 expectations were $0.48. Operator: Good day and welcome to the CorMedix Third Quarter 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn [….]

Thu Nov 13, 2025

$11.21 | -1.84%

Earnings

Needham Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 12 2025 Needham maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 73.23% Upside

Thu Nov 13, 2025

$11.21 | -1.84%

Rating

D. Boral Capital Maintains CorMedix (CRMD) Buy Recommendation. Fintel reports that on November 12 2025 D. Boral Capital maintained coverage of CorMedix (NasdaqGM:CRMD) with a Buy recommendation. Analyst Price Forecast Suggests 73.23% Upside

Thu Nov 13, 2025

$11.21 | -1.84%

Rating

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations. CRMD) reported third-quarter earningsSales reached $104.27 million a jump from $11.5 million a year ago beating the .Net revenue of $104.3 million and pro forma net revenue of $130.8 million were primarily driven by higher-than-expected utilization of DefenCath by its .DefenCath sales contributed $88.8 million of net revenue in ...

Wed Nov 12, 2025

$11.38 | +2.06%

Earnings

Momentum

CorMedix GAAP EPS of $1.26 beats by $0.63 revenue of $104.28M beats by $18.26M.

Wed Nov 12, 2025

$11.38 | +2.06%

Earnings

CorMedix raises 2025 revenue guidance to $390M-$410M amid accelerated Melinta integration and DefenCath momentum.

Wed Nov 12, 2025

$11.38 | +2.06%

Potential

Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Heres What You Should Know. The mean of analysts price targets for CorMedix (CRMD) points to an 80.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Mon Nov 10, 2025

$11.05 | +2.97%

Potential

All You Need to Know About CorMedix (CRMD) Rating Upgrade to Strong Buy. CorMedix (CRMD) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

Tue Nov 4, 2025

$11.42 | -1.30%

Momentum

Rating

Tuesday 10/28 Insider Buying Report: CRMD XFOR. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Thursday CorMedixs Director Myron Kaplan made a $275500 buy of CRMD purcha

Tue Oct 28, 2025

$11.14 | +0.81%

Activity

Momentum

Discover CRMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRMD. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CRMD Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRMD Stock trends

CRMD Stock performance

CRMD Stock analysis

CRMD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRMD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CRMD Stock Analysis & IQ Rating | CorMedix

CRMD Stock IQ

CRMD Target Price

CRMD Risk Level

CRMD Analysts Opinion

CRMD Street Sentiment

CRMD Performance Sentiment

Technical Price Levels

Explore our CRMD Stock insights

Receive our CRMD Daily Alerts

CRMD Stock IQ

CRMD Street Sentiment

CRMD Risk Level

Technical Price Levels

Discover CRMD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRMD. We're here to help you make informed investment decisions today.

Receive our CRMD Daily Alerts

CRMD Runner Alarm